Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est
Benzinga Newsdesk 6 months ago
NewsGuidance
2026 GuidanceFull year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million
2026 Guidance
- Full year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million